General Updates

22nd October 2026 Manager – Listing Department Manager – Listing BSE Ltd. National Stock Exchange of India Ltd Mumbai 400 001 Mumbai 400 051 Scrip Code: 524816 Scrip Code: NATCOPHARM Dear Sir/Madam, Sub: Intimation of closure of the Issue period of the Rights Issue of NATCO Pharma Limited (the “Company”) This is to inform you that the meeting of the Board of Directors of the Company held on 25th September, 2026 approved the terms of the issuance of equity shares of the Company of face value of Rs.2/- each for cash at a price of Rs.750/- each by way of Rights Issue for an amount aggregating up to Rs.12,794 millions ("Issue"), in accordance with the Companies Act, 2013 and the rules made thereunder, as amended, the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended, and other applicable laws. In view thereof, please note that the Issue opened on Monday, October 12, 2026 and will close today i.e. Thursday, October, 22, 2026. We request you to kindly take the above information on record. Thanking you Yours faithfully For NATCO Pharma Limited Ch. Venkat Ramesh Company Secretary & Compliance Officer